Among them, the most frequent patients in the ASS group were with the anti-Jo-1 antibody, while in the DM group was the anti-MDA5 antibody, and notably, 26 of all 46 patients had a combination of the anti-Ro-52 antibody. This evidence concerns the gene IFIH1 and dermatomyositis.